Compare Amylx Pharmaceuticals Inc (AMLX) vs HSBC Holdings plc (HSBC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs HSBC Holdings plc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.72 (market cap $2.64B), while HSBC Holdings plc trades at $103.88 (market cap $353.82B). The key difference: HSBC Holdings plc is far larger — about 134× Amylx Pharmaceuticals Inc's market cap, and HSBC Holdings plc pays a 3.63% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | HSBC | |
|---|---|---|
Market Cap | $2.64B | $353.82B |
Sector | Health | Technology |
52-Week High | $24.19 | $107.86 |
52-Week Low | $7.82 | $63.84 |
Enterprise Value | $2.39B | — |
Dividend Yield | — | 3.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About HSBC Holdings plc
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →
